Hymon® is a urine-based diagnostic test for bladder cancer screening that detects biomarkers associated with malignant urothelial disease. The test provides non-invasive risk stratification for patients with hematuria or suspected bladder pathology, enabling early detection and clinical decision-mak...
Manufactured by
Suzhou, Jiangsu, China
HymonBio Co., Ltd. was established in 2015, with co-founder from the Chinese Academy of Sciences. The company focuses on the development, production, and sale of precision-medicine and point-of-care (POCT) related products. Since its establishment in Taicang BIOBAY, HymonBio has applied for 36 patents and obtained 16 authorized patents; 11 products have obtained Chinese medical device certificates; 59 products have obtained CE certificates; 1 product has obtained an FDA certificate and passed the ISO13485 system certificate. The company has won awards such as high-tech enterprises, private technology enterprises in Jiangsu Province, enterprises supported by the Double Innovation Plan of Jiangsu Province, and Suzhou Female Innovation and Entrepreneurship Leading Talent Enterprises. Most recently, HymonBio has completed the first round of financing, which is also the first overseas investment project of PerkinElmer Ventures, a leading company in the IVD industry, in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biomerica, Inc.
United States · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 1 relevant product
ACON Laboratories, Inc.
United States · 2 relevant products
50 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 71 closest product alternatives
Biomerica, Inc. · United States
An advanced diagnostic test for prostate cancer screening. Designed as an at-home screening product targeting high-prevalence cancer detection.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based diagnostic test for early detection and risk assessment of hepatocellular carcinoma. Provides comprehensive screening capabilities for liver cancer malignancies.
Biomerica, Inc. · United States
A diagnostic test targeting men's health conditions including prostate cancer screening. Supports disease detection in high-prevalence male populations.
68 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products